Veru Phase 2 Development Of Veru-100 And Zuclomiphene Assets Will Be Paused; Is Reserving Sabizabulin For Clinical Development Only In Infectious Disease Indications, Terminating Phase 3 Veracity Trial Of Sabizabulin In Certain Prostate Cancer Patients
